Literature DB >> 8101552

Chlamydia trachomatis serovars in 435 urogenital specimens typed by restriction endonuclease analysis of amplified DNA.

E H Frost1, S Deslandes, D Bourgaux-Ramoisy.   

Abstract

Chlamydia trachomatis serovar was determined by analysis of restriction fragment length polymorphism in the gene encoding the major outer membrane protein (MOMP) from 435 urogenital specimens. Of the specimens, 254 grew < 25 inclusions and 14 were negative in culture. Although previous studies defined serovar by epitopes or sequences representing only the four variable domains in MOMP, restriction endonuclease sites characteristic for each serovar not only within but also outside these variable domains were cataloged in this study. Novel serovars that grew poorly or not at all in vitro were not observed, and all samples proved similar or identical to one of the 15 known serovars. There was no significant difference in proportions of serovars between men and women. In women, F serovars were more frequently observed in infections with few inclusions in culture, whereas B group serovars predominated when many inclusions were observed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8101552     DOI: 10.1093/infdis/168.2.497

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Distribution of Chlamydia trachomatis serotypes in clinical urogenital samples from north-eastern Croatia.

Authors:  Zinka Bošnjak; Snježana Džijan; Dinko Pavlinić; Magdalena Perić; Nataša Ružman; Ivana Roksandić Križan; Gordan Lauc; Arlen Antolović-Požgain; Jelena Burazin; Dubravka Vuković
Journal:  Curr Microbiol       Date:  2012-03-11       Impact factor: 2.188

2.  Population-based genetic and evolutionary analysis of Chlamydia trachomatis urogenital strain variation in the United States.

Authors:  Kim Millman; Carolyn M Black; Robert E Johnson; Walter E Stamm; Robert B Jones; Edward W Hook; David H Martin; Gail Bolan; Simon Tavaré; Deborah Dean
Journal:  J Bacteriol       Date:  2004-04       Impact factor: 3.490

3.  Late-stage inclusion body conjunctivitis: trachoma?

Authors:  Martin Zinkernagel; Elena Catalano; Dagmar Ammann-Rauch
Journal:  Br J Ophthalmol       Date:  2007-03       Impact factor: 4.638

4.  Genotyping of Portuguese Chlamydia trachomatis urogenital isolates.

Authors:  M J Borrego; J P Gomes; J F Lefebvre; F Eb; J Orfila; M A Catry
Journal:  Genitourin Med       Date:  1997-12

5.  Chlamydia trachomatis serovar distribution and Neisseria gonorrhoeae coinfection in male patients with urethritis in Greece.

Authors:  Helen Papadogeorgakis; Theodore E Pittaras; Joseph Papaparaskevas; Vassiliki Pitiriga; Andreas Katsambas; Athanassios Tsakris
Journal:  J Clin Microbiol       Date:  2010-03-31       Impact factor: 5.948

6.  Sensitivity of a commercial polymerase chain reaction for different serovars of Chlamydia trachomatis present at low titre in clinical samples.

Authors:  E H Frost; S Deslandes; D Bourgaux-Ramoisy; P Bourgaux
Journal:  Genitourin Med       Date:  1995-10

7.  Comparison of two panels of monoclonal antibodies for determination of Chlamydia trachomatis serovars.

Authors:  J M Ossewaarde; M Rieffe; A de Vries; R P Derksen-Nawrocki; H J Hooft; G J van Doornum; A M van Loon
Journal:  J Clin Microbiol       Date:  1994-12       Impact factor: 5.948

Review 8.  Diagnosis and assessment of trachoma.

Authors:  Anthony W Solomon; Rosanna W Peeling; Allen Foster; David C W Mabey
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Quantitation of Chlamydia trachomatis by culture, direct immunofluorescence and competitive polymerase chain reaction.

Authors:  E H Frost; S Deslandes; D Bourgaux-Ramoisy; P Bourgaux
Journal:  Genitourin Med       Date:  1995-08

10.  Absence of lymphogranuloma venereum strains among rectal Chlamydia trachomatis outer membrane protein A genotypes infecting women and men who have sex with men in Birmingham, Alabama.

Authors:  William M Geisler; Sandra G Morrison; Laura H Bachmann
Journal:  Sex Transm Dis       Date:  2008-10       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.